Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

The data, presented in a poster titled "AP402, a bispecific antibody targeting p95HER2 and CD137, shows potent antitumor activity," highlight the therapeutic potential of AP402 to address ...

Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. The standard ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...